Northern Trust
TERN

Northern Trust’s Terns Pharmaceuticals TERN Stock Holding History

Northern Trust’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.5M Buy
805,236
+140,792
+21% +$5.78M 0.01% 1210
2025
Q4 		$26.8M Buy
664,444
+76,899
+13% +$1.78M ﹤0.01% 1483
2025
Q3 		$4.41M Buy
587,545
+16,764
+3% +$107K ﹤0.01% 2570
2025
Q2 		$2.13M Sell
570,781
-13,407
-2% -$41.9K ﹤0.01% 2943
2025
Q1 		$1.61M Sell
584,188
-6,983
-1% -$28.5K ﹤0.01% 3034
2024
Q4 		$3.28M Buy
591,171
+127,296
+27% +$862K ﹤0.01% 2760
2024
Q3 		$3.87M Buy
463,875
+116,108
+33% +$955K ﹤0.01% 2627
2024
Q2 		$2.37M Sell
347,767
-8,029
-2% -$48.6K ﹤0.01% 2810
2024
Q1 		$2.33M Sell
355,796
-2,708
-0.8% -$17.7K ﹤0.01% 2879
2023
Q4 		$2.33M Buy
358,504
+10,184
+3% +$53.8K ﹤0.01% 2907
2023
Q3 		$1.75M Sell
348,320
-13,295
-4% -$84.4K ﹤0.01% 3014
2023
Q2 		$3.16M Buy
361,615
+306,536
+557% +$3.57M ﹤0.01% 2755
2023
Q1 		$652K Buy
55,079
+23,486
+74% +$224K ﹤0.01% 3354
2022
Q4 		$322K Buy
31,593
+10,089
+47% +$67.2K ﹤0.01% 3653
2022
Q3 		$127K Buy
21,504
+7,131
+50% +$26.5K ﹤0.01% 4033
2022
Q2 		$36K Sell
14,373
-90,449
-86% -$181K ﹤0.01% 4502
2022
Q1 		$311K Sell
104,822
-7,214
-6% -$30.8K ﹤0.01% 3933
2021
Q4 		$792K Sell
112,036
-4,880
-4% -$40.6K ﹤0.01% 3630
2021
Q3 		$1.22M Buy
116,916
+30,133
+35% +$313K ﹤0.01% 3489
2021
Q2 		$1.06M Sell
86,783
-5,004
-5% -$85.2K ﹤0.01% 3513
2021
Q1 		$2.02M Buy
+91,787
New +$2.01M ﹤0.01% 3236

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Northern Trust's TERN Position: Q1 2026 in Review

Northern Trust increased its Terns Pharmaceuticals (TERN) stake by 21% in Q1 2026, buying an estimated $5.78M and bringing the position to 805,236 shares worth $42.5M. The position accounts for 0.01% of the portfolio, ranked #1210.

Northern Trust first reported a position in TERN in Q1 2021 and has held it in 21 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Northern Trust held 805,236 shares of Terns Pharmaceuticals worth $42.5M as of Q1 2026.
  • Northern Trust bought 140,792 Terns Pharmaceuticals shares in Q1 2026, an estimated $5.78M.
  • Terns Pharmaceuticals made up 0.01% of Northern Trust's portfolio in Q1 2026, its #1210 holding.
  • Northern Trust first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.